health
New Treatment Cuts “Bad” Cholesterol in Half for a Full Year
A single infusion of an experimental CRISPR-Cas9 therapy was reported to safely lower LDL cholesterol by 52.5% and triglycerides by 47.8%, as measured 12 months after treatment. What if one infusion could keep cholesterol down for a year? An experimental gene-editing treatment called CTX310 has shown early promise in people whose cholesterol and other blood [...]
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories
Dad says he went permanently blind
New York Post
I'm a woman in my 20s and I'm not have the sex I want. I know what's holding me back.
Slate
Millions of cancer cases are linked to 5 common infections: study
New York Post
45-year-old man died after ER sent him home without antibiotics, lawsuit says
OregonLive.com
19 Harmless Symptoms That Are Major Medical Red Flags
BuzzFeed